According to the Zhitong Finance App, Laimei Pharmaceutical (300006.SZ) announced that Qiu Yu, a shareholder holding more than 5% of the company's shares, is overdue because of overdue debts relating to pledged securities repurchase business with Guohai Securities Co., Ltd. (“Guohai Securities”). Guohai Securities plans to follow the “Notice of Assistance in Enforcement” issued by the People's Court of Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region [(2023) Gui 0103, No. 3248] to continue to dispose of Qiu Yu's 7.554 million shares through centralized bidding. The current holdings reduction plan will be carried out within 3 months after 15 trading days (November 5, 2024) from the date of disclosure of this announcement, and the total number of shares reduced through centralized bidding transactions within any 90 consecutive natural days will not exceed 1% of the total number of shares of the company.

Zhitongcaijing · 10/14 13:57
According to the Zhitong Finance App, Laimei Pharmaceutical (300006.SZ) announced that Qiu Yu, a shareholder holding more than 5% of the company's shares, is overdue because of overdue debts relating to pledged securities repurchase business with Guohai Securities Co., Ltd. (“Guohai Securities”). Guohai Securities plans to follow the “Notice of Assistance in Enforcement” issued by the People's Court of Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region [(2023) Gui 0103, No. 3248] to continue to dispose of Qiu Yu's 7.554 million shares through centralized bidding. The current holdings reduction plan will be carried out within 3 months after 15 trading days (November 5, 2024) from the date of disclosure of this announcement, and the total number of shares reduced through centralized bidding transactions within any 90 consecutive natural days will not exceed 1% of the total number of shares of the company.